| Seyedeh Maryam Bashiri, MD | |
|
4010 S Mulberry St, Pine Bluff, AR 71603-7000 | |
| (870) 541-6000 | |
| Not Available |
| Full Name | Seyedeh Maryam Bashiri |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 14 Years |
| Location | 4010 S Mulberry St, Pine Bluff, Arkansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477900850 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Santa Rosa Memorial Hospital | Santa rosa, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Providence Medical Foundation | 8921993205 | 1293 |
News Archive
The National Institutes of Health (NIH) announced today that Martin J. Blaser, MD, the Frederick H. King Professor of Internal Medicine at NYU Langone Medical Center has been awarded one of only twenty NIH Director's Transformative Research Projects (T-R01) award for research entitled "Disappearing Gastrointestinal Microbiota in Epidemic Obesity.
A recent analysis conducted by the Associated Press revealed that the 20 states with civil commitment laws will spend nearly $500 million in 2010 to incarcerate only 5,000 offenders. According to experts at the Boston-based Institute for Sexual Wellness (ISW), states concerned with how to pay for these programs over the long term should investigate community-based programs. Not only are such programs available at a fraction of the cost of civil commitment, but they are demonstrating high success in preventing recidivism.
Researchers at the Dana-Farber Cancer Institute (Dana-Farber), Burnham Institute for Medical Research (Burnham) and the Centers for Disease Control and Prevention (CDC) have reported the identification of human monoclonal antibodies (mAb) that neutralize an unprecedented range of influenza A viruses, including avian influenza A (H5N1) virus, previous pandemic influenza viruses, and some seasonal influenza viruses.
Rexahn Pharmaceuticals, Inc. a clinical stage biopharmaceutical company developing best-in-class therapeutics for the treatment of cancer, is providing an overview of its three clinical development programs and Year for the year ended December 31, 2013.
› Verified 2 days ago
| Entity Name | Northbay Healthcare Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821147786 PECOS PAC ID: 0042122244 Enrollment ID: O20031105000409 |
News Archive
The National Institutes of Health (NIH) announced today that Martin J. Blaser, MD, the Frederick H. King Professor of Internal Medicine at NYU Langone Medical Center has been awarded one of only twenty NIH Director's Transformative Research Projects (T-R01) award for research entitled "Disappearing Gastrointestinal Microbiota in Epidemic Obesity.
A recent analysis conducted by the Associated Press revealed that the 20 states with civil commitment laws will spend nearly $500 million in 2010 to incarcerate only 5,000 offenders. According to experts at the Boston-based Institute for Sexual Wellness (ISW), states concerned with how to pay for these programs over the long term should investigate community-based programs. Not only are such programs available at a fraction of the cost of civil commitment, but they are demonstrating high success in preventing recidivism.
Researchers at the Dana-Farber Cancer Institute (Dana-Farber), Burnham Institute for Medical Research (Burnham) and the Centers for Disease Control and Prevention (CDC) have reported the identification of human monoclonal antibodies (mAb) that neutralize an unprecedented range of influenza A viruses, including avian influenza A (H5N1) virus, previous pandemic influenza viruses, and some seasonal influenza viruses.
Rexahn Pharmaceuticals, Inc. a clinical stage biopharmaceutical company developing best-in-class therapeutics for the treatment of cancer, is providing an overview of its three clinical development programs and Year for the year ended December 31, 2013.
› Verified 2 days ago
| Entity Name | Providence Medical Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285890624 PECOS PAC ID: 8921993205 Enrollment ID: O20040216001346 |
News Archive
The National Institutes of Health (NIH) announced today that Martin J. Blaser, MD, the Frederick H. King Professor of Internal Medicine at NYU Langone Medical Center has been awarded one of only twenty NIH Director's Transformative Research Projects (T-R01) award for research entitled "Disappearing Gastrointestinal Microbiota in Epidemic Obesity.
A recent analysis conducted by the Associated Press revealed that the 20 states with civil commitment laws will spend nearly $500 million in 2010 to incarcerate only 5,000 offenders. According to experts at the Boston-based Institute for Sexual Wellness (ISW), states concerned with how to pay for these programs over the long term should investigate community-based programs. Not only are such programs available at a fraction of the cost of civil commitment, but they are demonstrating high success in preventing recidivism.
Researchers at the Dana-Farber Cancer Institute (Dana-Farber), Burnham Institute for Medical Research (Burnham) and the Centers for Disease Control and Prevention (CDC) have reported the identification of human monoclonal antibodies (mAb) that neutralize an unprecedented range of influenza A viruses, including avian influenza A (H5N1) virus, previous pandemic influenza viruses, and some seasonal influenza viruses.
Rexahn Pharmaceuticals, Inc. a clinical stage biopharmaceutical company developing best-in-class therapeutics for the treatment of cancer, is providing an overview of its three clinical development programs and Year for the year ended December 31, 2013.
› Verified 2 days ago
| Entity Name | Hospitalist Medicine Physicians Of California Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184663965 PECOS PAC ID: 8426062027 Enrollment ID: O20060202000956 |
News Archive
The National Institutes of Health (NIH) announced today that Martin J. Blaser, MD, the Frederick H. King Professor of Internal Medicine at NYU Langone Medical Center has been awarded one of only twenty NIH Director's Transformative Research Projects (T-R01) award for research entitled "Disappearing Gastrointestinal Microbiota in Epidemic Obesity.
A recent analysis conducted by the Associated Press revealed that the 20 states with civil commitment laws will spend nearly $500 million in 2010 to incarcerate only 5,000 offenders. According to experts at the Boston-based Institute for Sexual Wellness (ISW), states concerned with how to pay for these programs over the long term should investigate community-based programs. Not only are such programs available at a fraction of the cost of civil commitment, but they are demonstrating high success in preventing recidivism.
Researchers at the Dana-Farber Cancer Institute (Dana-Farber), Burnham Institute for Medical Research (Burnham) and the Centers for Disease Control and Prevention (CDC) have reported the identification of human monoclonal antibodies (mAb) that neutralize an unprecedented range of influenza A viruses, including avian influenza A (H5N1) virus, previous pandemic influenza viruses, and some seasonal influenza viruses.
Rexahn Pharmaceuticals, Inc. a clinical stage biopharmaceutical company developing best-in-class therapeutics for the treatment of cancer, is providing an overview of its three clinical development programs and Year for the year ended December 31, 2013.
› Verified 2 days ago
| Entity Name | Hospitalist Medicine Physicians Of California - Fairfield Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487132007 PECOS PAC ID: 3779836085 Enrollment ID: O20181101002925 |
News Archive
The National Institutes of Health (NIH) announced today that Martin J. Blaser, MD, the Frederick H. King Professor of Internal Medicine at NYU Langone Medical Center has been awarded one of only twenty NIH Director's Transformative Research Projects (T-R01) award for research entitled "Disappearing Gastrointestinal Microbiota in Epidemic Obesity.
A recent analysis conducted by the Associated Press revealed that the 20 states with civil commitment laws will spend nearly $500 million in 2010 to incarcerate only 5,000 offenders. According to experts at the Boston-based Institute for Sexual Wellness (ISW), states concerned with how to pay for these programs over the long term should investigate community-based programs. Not only are such programs available at a fraction of the cost of civil commitment, but they are demonstrating high success in preventing recidivism.
Researchers at the Dana-Farber Cancer Institute (Dana-Farber), Burnham Institute for Medical Research (Burnham) and the Centers for Disease Control and Prevention (CDC) have reported the identification of human monoclonal antibodies (mAb) that neutralize an unprecedented range of influenza A viruses, including avian influenza A (H5N1) virus, previous pandemic influenza viruses, and some seasonal influenza viruses.
Rexahn Pharmaceuticals, Inc. a clinical stage biopharmaceutical company developing best-in-class therapeutics for the treatment of cancer, is providing an overview of its three clinical development programs and Year for the year ended December 31, 2013.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Seyedeh Maryam Bashiri, MD 4010 S Mulberry St, Pine Bluff, AR 71603-7000 Ph: (870) 541-6000 | Seyedeh Maryam Bashiri, MD 4010 S Mulberry St, Pine Bluff, AR 71603-7000 Ph: (870) 541-6000 |
News Archive
The National Institutes of Health (NIH) announced today that Martin J. Blaser, MD, the Frederick H. King Professor of Internal Medicine at NYU Langone Medical Center has been awarded one of only twenty NIH Director's Transformative Research Projects (T-R01) award for research entitled "Disappearing Gastrointestinal Microbiota in Epidemic Obesity.
A recent analysis conducted by the Associated Press revealed that the 20 states with civil commitment laws will spend nearly $500 million in 2010 to incarcerate only 5,000 offenders. According to experts at the Boston-based Institute for Sexual Wellness (ISW), states concerned with how to pay for these programs over the long term should investigate community-based programs. Not only are such programs available at a fraction of the cost of civil commitment, but they are demonstrating high success in preventing recidivism.
Researchers at the Dana-Farber Cancer Institute (Dana-Farber), Burnham Institute for Medical Research (Burnham) and the Centers for Disease Control and Prevention (CDC) have reported the identification of human monoclonal antibodies (mAb) that neutralize an unprecedented range of influenza A viruses, including avian influenza A (H5N1) virus, previous pandemic influenza viruses, and some seasonal influenza viruses.
Rexahn Pharmaceuticals, Inc. a clinical stage biopharmaceutical company developing best-in-class therapeutics for the treatment of cancer, is providing an overview of its three clinical development programs and Year for the year ended December 31, 2013.
› Verified 2 days ago
Carla Yvonne Pumphrey, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 4010 S Mulberry St, Pine Bluff, AR 71603 Phone: 870-541-6000 |